The Colossal Foundation is partnering with the University of Tasmania on an initiative to fight a facial cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s. [Photo: Colossal Foundation]
By using a vaccine and gene editing, the partners aim to fight a lethal cancer that has reduced the wild population of Tasmanian devils by 80% since the 1990s.
UT Southwestern Medical Center and pharmaceutical company Pfizer have teamed up to develop new ways to deliver genetic treatments to patients.
Together they aim to accelerate the development of therapies that work through RNA biology and engineered delivery methods to fix root genetic causes of disease, which Pfizer could apply to its portfolio of investigational programs.
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
The deal with Fresenius Kabi aims to bring innovative cell and gene treatments closer to patients by advancing Lupagen’s proprietary cell and gene therapy delivery system, the companies said. Their "to the bedside" approach could help open cutting-edge treatments to local hospitals and patients worldwide.
The Tasmanian tiger went extinct due to human hunting nearly 100 years ago. Now Dallas-based Colossal Biosciences aims to bring it back with the help of "marsupial biobanking." [Image: Colossal Biosciences]
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
The biotech company uses CRISPR technology licensed from UT Southwestern Medical Center in Dallas, and was co-founded by UTSW researcher and faculty member Eric Olson.
Also, you'll learn about advances to treat Duchenne muscular dystrophy and migraines. Here are some of the research projects underway in North Texas that could make lives better.
Texas Woman’s University Dallas, an offshoot of TWU in Denton, plans to open a campus for its proposed Pioneer College next fall in the burgeoning Y’all Street financial district.
The TWU System Board of Regents recently authorized TWU Dallas to negotiate a lease for 31,000 square feet at 1201 Main St....
The University of Texas at Arlington just unveiled a master plan for its new outpost in west Fort Worth that calls for a 1.6 million-square-foot campus accommodating up to 10,000 students....
Two Austin startups that spun out of Dallas-based de-extinction behemoth Colossal Biosciences are coming together to tackle challenges in designing genetic medicine.
Astromech, an AI company developing models to predict changes in living systems, said today it acquired Form Bio, a business that creates models and tools for designing genetic medicines....
Texas Woman’s University Dallas, an offshoot of TWU in Denton, plans to open a campus for its proposed Pioneer College next fall in the burgeoning Y’all Street financial district.
The TWU System Board of Regents recently authorized TWU Dallas to negotiate a lease for 31,000 square feet at 1201 Main St....
The University of Texas at Arlington just unveiled a master plan for its new outpost in west Fort Worth that calls for a 1.6 million-square-foot campus accommodating up to 10,000 students....
Two Austin startups that spun out of Dallas-based de-extinction behemoth Colossal Biosciences are coming together to tackle challenges in designing genetic medicine.
Astromech, an AI company developing models to predict changes in living systems, said today it acquired Form Bio, a business that creates models and tools for designing genetic medicines....